NervGen Pharma Corp. Common stock
Status: Publicly traded
Direct answer
NervGen Pharma Corp. Common stock is publicly traded on NASDAQ under the ticker NGEN.
NervGen Pharma Corp. is a biotechnology enterprise currently in its clinical development phase, focused on devising therapeutic solutions for nerve injuries and progressive neurodegenerative diseases. Their innovative approach centers on deactivating the natural biological mechanisms that typically impede the nervous system's ability to repair itself.
Can you invest in NervGen Pharma Corp. Common stock?
Yes. NervGen Pharma Corp. Common stock is publicly traded on NASDAQ under the ticker NGEN.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for NervGen Pharma Corp. Common stock
Detailed equity research is provided by MarketSnap.